Global Covid-19 Diagnostic Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Covid-19 Diagnostic market size was valued at US$ million in 2023. With growing demand in downstream market, the Covid-19 Diagnostic is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Covid-19 Diagnostic market. Covid-19 Diagnostic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Covid-19 Diagnostic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Covid-19 Diagnostic market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Covid-19 Diagnostic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Covid-19 Diagnostic market. It may include historical data, market segmentation by Type (e.g., Immunoassay, Genomic and WGS Role), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Covid-19 Diagnostic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Covid-19 Diagnostic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Covid-19 Diagnostic industry. This include advancements in Covid-19 Diagnostic technology, Covid-19 Diagnostic new entrants, Covid-19 Diagnostic new investment, and other innovations that are shaping the future of Covid-19 Diagnostic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Covid-19 Diagnostic market. It includes factors influencing customer ' purchasing decisions, preferences for Covid-19 Diagnostic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Covid-19 Diagnostic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Covid-19 Diagnostic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Covid-19 Diagnostic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Covid-19 Diagnostic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Covid-19 Diagnostic market.
Market Segmentation:
Covid-19 Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Covid-19 Diagnostic market size was valued at US$ million in 2023. With growing demand in downstream market, the Covid-19 Diagnostic is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Covid-19 Diagnostic market. Covid-19 Diagnostic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Covid-19 Diagnostic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Covid-19 Diagnostic market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Covid-19 Diagnostic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Covid-19 Diagnostic market. It may include historical data, market segmentation by Type (e.g., Immunoassay, Genomic and WGS Role), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Covid-19 Diagnostic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Covid-19 Diagnostic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Covid-19 Diagnostic industry. This include advancements in Covid-19 Diagnostic technology, Covid-19 Diagnostic new entrants, Covid-19 Diagnostic new investment, and other innovations that are shaping the future of Covid-19 Diagnostic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Covid-19 Diagnostic market. It includes factors influencing customer ' purchasing decisions, preferences for Covid-19 Diagnostic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Covid-19 Diagnostic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Covid-19 Diagnostic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Covid-19 Diagnostic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Covid-19 Diagnostic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Covid-19 Diagnostic market.
Market Segmentation:
Covid-19 Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Immunoassay
- Genomic and WGS Role
- rRT-PCR
- Hospital
- Laboratory
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Diagnostics
- Accelerate Diagnostics
- Ador Diagnostics
- Akkoni Biosystems
- Alveo Technologies
- Applied BioCode
- Aus Diagnostics
- BD Diagnostics
- Biocartis
- BioFire Diagnostics
- bioMйrieux
- Bio-Rad Laboratories
- Bosch Healthcare Solutions GmbH
- Cepheid
- Co-Diagnostics
- Cue Health
- Curetis
- Diagenode Diagnostics
- Diascopic
- Diasorin
- Expedeon
- Fusion Genomics.
- GenePOC Diagnostics
- GenMark Dx
- Hologic
- Immunexpress
- Inflammatix
- Invetech
- Janssen Diagnostics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Covid-19 Diagnostic Market Size 2019-2030
2.1.2 Covid-19 Diagnostic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Covid-19 Diagnostic Segment by Type
2.2.1 Immunoassay
2.2.2 Genomic and WGS Role
2.2.3 rRT-PCR
2.3 Covid-19 Diagnostic Market Size by Type
2.3.1 Covid-19 Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Covid-19 Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.5 Covid-19 Diagnostic Market Size by Application
2.5.1 Covid-19 Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
3 COVID-19 DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Covid-19 Diagnostic Market Size Market Share by Players
3.1.1 Global Covid-19 Diagnostic Revenue by Players (2019-2024)
3.1.2 Global Covid-19 Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Covid-19 Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COVID-19 DIAGNOSTIC BY REGIONS
4.1 Covid-19 Diagnostic Market Size by Regions (2019-2024)
4.2 Americas Covid-19 Diagnostic Market Size Growth (2019-2024)
4.3 APAC Covid-19 Diagnostic Market Size Growth (2019-2024)
4.4 Europe Covid-19 Diagnostic Market Size Growth (2019-2024)
4.5 Middle East & Africa Covid-19 Diagnostic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Covid-19 Diagnostic Market Size by Country (2019-2024)
5.2 Americas Covid-19 Diagnostic Market Size by Type (2019-2024)
5.3 Americas Covid-19 Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covid-19 Diagnostic Market Size by Region (2019-2024)
6.2 APAC Covid-19 Diagnostic Market Size by Type (2019-2024)
6.3 APAC Covid-19 Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Covid-19 Diagnostic by Country (2019-2024)
7.2 Europe Covid-19 Diagnostic Market Size by Type (2019-2024)
7.3 Europe Covid-19 Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Covid-19 Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COVID-19 DIAGNOSTIC MARKET FORECAST
10.1 Global Covid-19 Diagnostic Forecast by Regions (2025-2030)
10.1.1 Global Covid-19 Diagnostic Forecast by Regions (2025-2030)
10.1.2 Americas Covid-19 Diagnostic Forecast
10.1.3 APAC Covid-19 Diagnostic Forecast
10.1.4 Europe Covid-19 Diagnostic Forecast
10.1.5 Middle East & Africa Covid-19 Diagnostic Forecast
10.2 Americas Covid-19 Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Covid-19 Diagnostic Market Forecast
10.2.2 Canada Covid-19 Diagnostic Market Forecast
10.2.3 Mexico Covid-19 Diagnostic Market Forecast
10.2.4 Brazil Covid-19 Diagnostic Market Forecast
10.3 APAC Covid-19 Diagnostic Forecast by Region (2025-2030)
10.3.1 China Covid-19 Diagnostic Market Forecast
10.3.2 Japan Covid-19 Diagnostic Market Forecast
10.3.3 Korea Covid-19 Diagnostic Market Forecast
10.3.4 Southeast Asia Covid-19 Diagnostic Market Forecast
10.3.5 India Covid-19 Diagnostic Market Forecast
10.3.6 Australia Covid-19 Diagnostic Market Forecast
10.4 Europe Covid-19 Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Covid-19 Diagnostic Market Forecast
10.4.2 France Covid-19 Diagnostic Market Forecast
10.4.3 UK Covid-19 Diagnostic Market Forecast
10.4.4 Italy Covid-19 Diagnostic Market Forecast
10.4.5 Russia Covid-19 Diagnostic Market Forecast
10.5 Middle East & Africa Covid-19 Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Covid-19 Diagnostic Market Forecast
10.5.2 South Africa Covid-19 Diagnostic Market Forecast
10.5.3 Israel Covid-19 Diagnostic Market Forecast
10.5.4 Turkey Covid-19 Diagnostic Market Forecast
10.5.5 GCC Countries Covid-19 Diagnostic Market Forecast
10.6 Global Covid-19 Diagnostic Forecast by Type (2025-2030)
10.7 Global Covid-19 Diagnostic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Information
11.1.2 Abbott Diagnostics Covid-19 Diagnostic Product Offered
11.1.3 Abbott Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Diagnostics Main Business Overview
11.1.5 Abbott Diagnostics Latest Developments
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Information
11.2.2 Accelerate Diagnostics Covid-19 Diagnostic Product Offered
11.2.3 Accelerate Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Accelerate Diagnostics Main Business Overview
11.2.5 Accelerate Diagnostics Latest Developments
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Information
11.3.2 Ador Diagnostics Covid-19 Diagnostic Product Offered
11.3.3 Ador Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ador Diagnostics Main Business Overview
11.3.5 Ador Diagnostics Latest Developments
11.4 Akkoni Biosystems
11.4.1 Akkoni Biosystems Company Information
11.4.2 Akkoni Biosystems Covid-19 Diagnostic Product Offered
11.4.3 Akkoni Biosystems Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Akkoni Biosystems Main Business Overview
11.4.5 Akkoni Biosystems Latest Developments
11.5 Alveo Technologies
11.5.1 Alveo Technologies Company Information
11.5.2 Alveo Technologies Covid-19 Diagnostic Product Offered
11.5.3 Alveo Technologies Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alveo Technologies Main Business Overview
11.5.5 Alveo Technologies Latest Developments
11.6 Applied BioCode
11.6.1 Applied BioCode Company Information
11.6.2 Applied BioCode Covid-19 Diagnostic Product Offered
11.6.3 Applied BioCode Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Applied BioCode Main Business Overview
11.6.5 Applied BioCode Latest Developments
11.7 Aus Diagnostics
11.7.1 Aus Diagnostics Company Information
11.7.2 Aus Diagnostics Covid-19 Diagnostic Product Offered
11.7.3 Aus Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aus Diagnostics Main Business Overview
11.7.5 Aus Diagnostics Latest Developments
11.8 BD Diagnostics
11.8.1 BD Diagnostics Company Information
11.8.2 BD Diagnostics Covid-19 Diagnostic Product Offered
11.8.3 BD Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BD Diagnostics Main Business Overview
11.8.5 BD Diagnostics Latest Developments
11.9 Biocartis
11.9.1 Biocartis Company Information
11.9.2 Biocartis Covid-19 Diagnostic Product Offered
11.9.3 Biocartis Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Biocartis Main Business Overview
11.9.5 Biocartis Latest Developments
11.10 BioFire Diagnostics
11.10.1 BioFire Diagnostics Company Information
11.10.2 BioFire Diagnostics Covid-19 Diagnostic Product Offered
11.10.3 BioFire Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BioFire Diagnostics Main Business Overview
11.10.5 BioFire Diagnostics Latest Developments
11.11 bioMйrieux
11.11.1 bioMйrieux Company Information
11.11.2 bioMйrieux Covid-19 Diagnostic Product Offered
11.11.3 bioMйrieux Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 bioMйrieux Main Business Overview
11.11.5 bioMйrieux Latest Developments
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Information
11.12.2 Bio-Rad Laboratories Covid-19 Diagnostic Product Offered
11.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bio-Rad Laboratories Main Business Overview
11.12.5 Bio-Rad Laboratories Latest Developments
11.13 Bosch Healthcare Solutions GmbH
11.13.1 Bosch Healthcare Solutions GmbH Company Information
11.13.2 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product Offered
11.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bosch Healthcare Solutions GmbH Main Business Overview
11.13.5 Bosch Healthcare Solutions GmbH Latest Developments
11.14 Cepheid
11.14.1 Cepheid Company Information
11.14.2 Cepheid Covid-19 Diagnostic Product Offered
11.14.3 Cepheid Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Cepheid Main Business Overview
11.14.5 Cepheid Latest Developments
11.15 Co-Diagnostics
11.15.1 Co-Diagnostics Company Information
11.15.2 Co-Diagnostics Covid-19 Diagnostic Product Offered
11.15.3 Co-Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Co-Diagnostics Main Business Overview
11.15.5 Co-Diagnostics Latest Developments
11.16 Cue Health
11.16.1 Cue Health Company Information
11.16.2 Cue Health Covid-19 Diagnostic Product Offered
11.16.3 Cue Health Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Cue Health Main Business Overview
11.16.5 Cue Health Latest Developments
11.17 Curetis
11.17.1 Curetis Company Information
11.17.2 Curetis Covid-19 Diagnostic Product Offered
11.17.3 Curetis Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Curetis Main Business Overview
11.17.5 Curetis Latest Developments
11.18 Diagenode Diagnostics
11.18.1 Diagenode Diagnostics Company Information
11.18.2 Diagenode Diagnostics Covid-19 Diagnostic Product Offered
11.18.3 Diagenode Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Diagenode Diagnostics Main Business Overview
11.18.5 Diagenode Diagnostics Latest Developments
11.19 Diascopic
11.19.1 Diascopic Company Information
11.19.2 Diascopic Covid-19 Diagnostic Product Offered
11.19.3 Diascopic Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Diascopic Main Business Overview
11.19.5 Diascopic Latest Developments
11.20 Diasorin
11.20.1 Diasorin Company Information
11.20.2 Diasorin Covid-19 Diagnostic Product Offered
11.20.3 Diasorin Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Diasorin Main Business Overview
11.20.5 Diasorin Latest Developments
11.21 Expedeon
11.21.1 Expedeon Company Information
11.21.2 Expedeon Covid-19 Diagnostic Product Offered
11.21.3 Expedeon Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Expedeon Main Business Overview
11.21.5 Expedeon Latest Developments
11.22 Fusion Genomics.
11.22.1 Fusion Genomics. Company Information
11.22.2 Fusion Genomics. Covid-19 Diagnostic Product Offered
11.22.3 Fusion Genomics. Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Fusion Genomics. Main Business Overview
11.22.5 Fusion Genomics. Latest Developments
11.23 GenePOC Diagnostics
11.23.1 GenePOC Diagnostics Company Information
11.23.2 GenePOC Diagnostics Covid-19 Diagnostic Product Offered
11.23.3 GenePOC Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 GenePOC Diagnostics Main Business Overview
11.23.5 GenePOC Diagnostics Latest Developments
11.24 GenMark Dx
11.24.1 GenMark Dx Company Information
11.24.2 GenMark Dx Covid-19 Diagnostic Product Offered
11.24.3 GenMark Dx Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 GenMark Dx Main Business Overview
11.24.5 GenMark Dx Latest Developments
11.25 Hologic
11.25.1 Hologic Company Information
11.25.2 Hologic Covid-19 Diagnostic Product Offered
11.25.3 Hologic Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Hologic Main Business Overview
11.25.5 Hologic Latest Developments
11.26 Immunexpress
11.26.1 Immunexpress Company Information
11.26.2 Immunexpress Covid-19 Diagnostic Product Offered
11.26.3 Immunexpress Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Immunexpress Main Business Overview
11.26.5 Immunexpress Latest Developments
11.27 Inflammatix
11.27.1 Inflammatix Company Information
11.27.2 Inflammatix Covid-19 Diagnostic Product Offered
11.27.3 Inflammatix Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Inflammatix Main Business Overview
11.27.5 Inflammatix Latest Developments
11.28 Invetech
11.28.1 Invetech Company Information
11.28.2 Invetech Covid-19 Diagnostic Product Offered
11.28.3 Invetech Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.28.4 Invetech Main Business Overview
11.28.5 Invetech Latest Developments
11.29 Janssen Diagnostics
11.29.1 Janssen Diagnostics Company Information
11.29.2 Janssen Diagnostics Covid-19 Diagnostic Product Offered
11.29.3 Janssen Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.29.4 Janssen Diagnostics Main Business Overview
11.29.5 Janssen Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Covid-19 Diagnostic Market Size 2019-2030
2.1.2 Covid-19 Diagnostic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Covid-19 Diagnostic Segment by Type
2.2.1 Immunoassay
2.2.2 Genomic and WGS Role
2.2.3 rRT-PCR
2.3 Covid-19 Diagnostic Market Size by Type
2.3.1 Covid-19 Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Covid-19 Diagnostic Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.5 Covid-19 Diagnostic Market Size by Application
2.5.1 Covid-19 Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
3 COVID-19 DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Covid-19 Diagnostic Market Size Market Share by Players
3.1.1 Global Covid-19 Diagnostic Revenue by Players (2019-2024)
3.1.2 Global Covid-19 Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Covid-19 Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COVID-19 DIAGNOSTIC BY REGIONS
4.1 Covid-19 Diagnostic Market Size by Regions (2019-2024)
4.2 Americas Covid-19 Diagnostic Market Size Growth (2019-2024)
4.3 APAC Covid-19 Diagnostic Market Size Growth (2019-2024)
4.4 Europe Covid-19 Diagnostic Market Size Growth (2019-2024)
4.5 Middle East & Africa Covid-19 Diagnostic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Covid-19 Diagnostic Market Size by Country (2019-2024)
5.2 Americas Covid-19 Diagnostic Market Size by Type (2019-2024)
5.3 Americas Covid-19 Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covid-19 Diagnostic Market Size by Region (2019-2024)
6.2 APAC Covid-19 Diagnostic Market Size by Type (2019-2024)
6.3 APAC Covid-19 Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Covid-19 Diagnostic by Country (2019-2024)
7.2 Europe Covid-19 Diagnostic Market Size by Type (2019-2024)
7.3 Europe Covid-19 Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Covid-19 Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COVID-19 DIAGNOSTIC MARKET FORECAST
10.1 Global Covid-19 Diagnostic Forecast by Regions (2025-2030)
10.1.1 Global Covid-19 Diagnostic Forecast by Regions (2025-2030)
10.1.2 Americas Covid-19 Diagnostic Forecast
10.1.3 APAC Covid-19 Diagnostic Forecast
10.1.4 Europe Covid-19 Diagnostic Forecast
10.1.5 Middle East & Africa Covid-19 Diagnostic Forecast
10.2 Americas Covid-19 Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Covid-19 Diagnostic Market Forecast
10.2.2 Canada Covid-19 Diagnostic Market Forecast
10.2.3 Mexico Covid-19 Diagnostic Market Forecast
10.2.4 Brazil Covid-19 Diagnostic Market Forecast
10.3 APAC Covid-19 Diagnostic Forecast by Region (2025-2030)
10.3.1 China Covid-19 Diagnostic Market Forecast
10.3.2 Japan Covid-19 Diagnostic Market Forecast
10.3.3 Korea Covid-19 Diagnostic Market Forecast
10.3.4 Southeast Asia Covid-19 Diagnostic Market Forecast
10.3.5 India Covid-19 Diagnostic Market Forecast
10.3.6 Australia Covid-19 Diagnostic Market Forecast
10.4 Europe Covid-19 Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Covid-19 Diagnostic Market Forecast
10.4.2 France Covid-19 Diagnostic Market Forecast
10.4.3 UK Covid-19 Diagnostic Market Forecast
10.4.4 Italy Covid-19 Diagnostic Market Forecast
10.4.5 Russia Covid-19 Diagnostic Market Forecast
10.5 Middle East & Africa Covid-19 Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Covid-19 Diagnostic Market Forecast
10.5.2 South Africa Covid-19 Diagnostic Market Forecast
10.5.3 Israel Covid-19 Diagnostic Market Forecast
10.5.4 Turkey Covid-19 Diagnostic Market Forecast
10.5.5 GCC Countries Covid-19 Diagnostic Market Forecast
10.6 Global Covid-19 Diagnostic Forecast by Type (2025-2030)
10.7 Global Covid-19 Diagnostic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Information
11.1.2 Abbott Diagnostics Covid-19 Diagnostic Product Offered
11.1.3 Abbott Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Diagnostics Main Business Overview
11.1.5 Abbott Diagnostics Latest Developments
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Information
11.2.2 Accelerate Diagnostics Covid-19 Diagnostic Product Offered
11.2.3 Accelerate Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Accelerate Diagnostics Main Business Overview
11.2.5 Accelerate Diagnostics Latest Developments
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Information
11.3.2 Ador Diagnostics Covid-19 Diagnostic Product Offered
11.3.3 Ador Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ador Diagnostics Main Business Overview
11.3.5 Ador Diagnostics Latest Developments
11.4 Akkoni Biosystems
11.4.1 Akkoni Biosystems Company Information
11.4.2 Akkoni Biosystems Covid-19 Diagnostic Product Offered
11.4.3 Akkoni Biosystems Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Akkoni Biosystems Main Business Overview
11.4.5 Akkoni Biosystems Latest Developments
11.5 Alveo Technologies
11.5.1 Alveo Technologies Company Information
11.5.2 Alveo Technologies Covid-19 Diagnostic Product Offered
11.5.3 Alveo Technologies Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alveo Technologies Main Business Overview
11.5.5 Alveo Technologies Latest Developments
11.6 Applied BioCode
11.6.1 Applied BioCode Company Information
11.6.2 Applied BioCode Covid-19 Diagnostic Product Offered
11.6.3 Applied BioCode Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Applied BioCode Main Business Overview
11.6.5 Applied BioCode Latest Developments
11.7 Aus Diagnostics
11.7.1 Aus Diagnostics Company Information
11.7.2 Aus Diagnostics Covid-19 Diagnostic Product Offered
11.7.3 Aus Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aus Diagnostics Main Business Overview
11.7.5 Aus Diagnostics Latest Developments
11.8 BD Diagnostics
11.8.1 BD Diagnostics Company Information
11.8.2 BD Diagnostics Covid-19 Diagnostic Product Offered
11.8.3 BD Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BD Diagnostics Main Business Overview
11.8.5 BD Diagnostics Latest Developments
11.9 Biocartis
11.9.1 Biocartis Company Information
11.9.2 Biocartis Covid-19 Diagnostic Product Offered
11.9.3 Biocartis Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Biocartis Main Business Overview
11.9.5 Biocartis Latest Developments
11.10 BioFire Diagnostics
11.10.1 BioFire Diagnostics Company Information
11.10.2 BioFire Diagnostics Covid-19 Diagnostic Product Offered
11.10.3 BioFire Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BioFire Diagnostics Main Business Overview
11.10.5 BioFire Diagnostics Latest Developments
11.11 bioMйrieux
11.11.1 bioMйrieux Company Information
11.11.2 bioMйrieux Covid-19 Diagnostic Product Offered
11.11.3 bioMйrieux Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 bioMйrieux Main Business Overview
11.11.5 bioMйrieux Latest Developments
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Information
11.12.2 Bio-Rad Laboratories Covid-19 Diagnostic Product Offered
11.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bio-Rad Laboratories Main Business Overview
11.12.5 Bio-Rad Laboratories Latest Developments
11.13 Bosch Healthcare Solutions GmbH
11.13.1 Bosch Healthcare Solutions GmbH Company Information
11.13.2 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product Offered
11.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bosch Healthcare Solutions GmbH Main Business Overview
11.13.5 Bosch Healthcare Solutions GmbH Latest Developments
11.14 Cepheid
11.14.1 Cepheid Company Information
11.14.2 Cepheid Covid-19 Diagnostic Product Offered
11.14.3 Cepheid Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Cepheid Main Business Overview
11.14.5 Cepheid Latest Developments
11.15 Co-Diagnostics
11.15.1 Co-Diagnostics Company Information
11.15.2 Co-Diagnostics Covid-19 Diagnostic Product Offered
11.15.3 Co-Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Co-Diagnostics Main Business Overview
11.15.5 Co-Diagnostics Latest Developments
11.16 Cue Health
11.16.1 Cue Health Company Information
11.16.2 Cue Health Covid-19 Diagnostic Product Offered
11.16.3 Cue Health Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Cue Health Main Business Overview
11.16.5 Cue Health Latest Developments
11.17 Curetis
11.17.1 Curetis Company Information
11.17.2 Curetis Covid-19 Diagnostic Product Offered
11.17.3 Curetis Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Curetis Main Business Overview
11.17.5 Curetis Latest Developments
11.18 Diagenode Diagnostics
11.18.1 Diagenode Diagnostics Company Information
11.18.2 Diagenode Diagnostics Covid-19 Diagnostic Product Offered
11.18.3 Diagenode Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Diagenode Diagnostics Main Business Overview
11.18.5 Diagenode Diagnostics Latest Developments
11.19 Diascopic
11.19.1 Diascopic Company Information
11.19.2 Diascopic Covid-19 Diagnostic Product Offered
11.19.3 Diascopic Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Diascopic Main Business Overview
11.19.5 Diascopic Latest Developments
11.20 Diasorin
11.20.1 Diasorin Company Information
11.20.2 Diasorin Covid-19 Diagnostic Product Offered
11.20.3 Diasorin Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Diasorin Main Business Overview
11.20.5 Diasorin Latest Developments
11.21 Expedeon
11.21.1 Expedeon Company Information
11.21.2 Expedeon Covid-19 Diagnostic Product Offered
11.21.3 Expedeon Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Expedeon Main Business Overview
11.21.5 Expedeon Latest Developments
11.22 Fusion Genomics.
11.22.1 Fusion Genomics. Company Information
11.22.2 Fusion Genomics. Covid-19 Diagnostic Product Offered
11.22.3 Fusion Genomics. Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Fusion Genomics. Main Business Overview
11.22.5 Fusion Genomics. Latest Developments
11.23 GenePOC Diagnostics
11.23.1 GenePOC Diagnostics Company Information
11.23.2 GenePOC Diagnostics Covid-19 Diagnostic Product Offered
11.23.3 GenePOC Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 GenePOC Diagnostics Main Business Overview
11.23.5 GenePOC Diagnostics Latest Developments
11.24 GenMark Dx
11.24.1 GenMark Dx Company Information
11.24.2 GenMark Dx Covid-19 Diagnostic Product Offered
11.24.3 GenMark Dx Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 GenMark Dx Main Business Overview
11.24.5 GenMark Dx Latest Developments
11.25 Hologic
11.25.1 Hologic Company Information
11.25.2 Hologic Covid-19 Diagnostic Product Offered
11.25.3 Hologic Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Hologic Main Business Overview
11.25.5 Hologic Latest Developments
11.26 Immunexpress
11.26.1 Immunexpress Company Information
11.26.2 Immunexpress Covid-19 Diagnostic Product Offered
11.26.3 Immunexpress Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Immunexpress Main Business Overview
11.26.5 Immunexpress Latest Developments
11.27 Inflammatix
11.27.1 Inflammatix Company Information
11.27.2 Inflammatix Covid-19 Diagnostic Product Offered
11.27.3 Inflammatix Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Inflammatix Main Business Overview
11.27.5 Inflammatix Latest Developments
11.28 Invetech
11.28.1 Invetech Company Information
11.28.2 Invetech Covid-19 Diagnostic Product Offered
11.28.3 Invetech Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.28.4 Invetech Main Business Overview
11.28.5 Invetech Latest Developments
11.29 Janssen Diagnostics
11.29.1 Janssen Diagnostics Company Information
11.29.2 Janssen Diagnostics Covid-19 Diagnostic Product Offered
11.29.3 Janssen Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.29.4 Janssen Diagnostics Main Business Overview
11.29.5 Janssen Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Covid-19 Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immunoassay
Table 3. Major Players of Genomic and WGS Role
Table 4. Major Players of rRT-PCR
Table 5. Covid-19 Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 8. Covid-19 Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 11. Global Covid-19 Diagnostic Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Covid-19 Diagnostic Revenue Market Share by Player (2019-2024)
Table 13. Covid-19 Diagnostic Key Players Head office and Products Offered
Table 14. Covid-19 Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Covid-19 Diagnostic Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Covid-19 Diagnostic Market Size Market Share by Regions (2019-2024)
Table 19. Global Covid-19 Diagnostic Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Covid-19 Diagnostic Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Covid-19 Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Covid-19 Diagnostic Market Size Market Share by Country (2019-2024)
Table 23. Americas Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 25. Americas Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 27. APAC Covid-19 Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Covid-19 Diagnostic Market Size Market Share by Region (2019-2024)
Table 29. APAC Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 31. APAC Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 33. Europe Covid-19 Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Covid-19 Diagnostic Market Size Market Share by Country (2019-2024)
Table 35. Europe Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 37. Europe Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Covid-19 Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Covid-19 Diagnostic
Table 46. Key Market Challenges & Risks of Covid-19 Diagnostic
Table 47. Key Industry Trends of Covid-19 Diagnostic
Table 48. Global Covid-19 Diagnostic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Covid-19 Diagnostic Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Covid-19 Diagnostic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Covid-19 Diagnostic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Abbott Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 53. Abbott Diagnostics Covid-19 Diagnostic Product Offered
Table 54. Abbott Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Abbott Diagnostics Main Business
Table 56. Abbott Diagnostics Latest Developments
Table 57. Accelerate Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 58. Accelerate Diagnostics Covid-19 Diagnostic Product Offered
Table 59. Accelerate Diagnostics Main Business
Table 60. Accelerate Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Accelerate Diagnostics Latest Developments
Table 62. Ador Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 63. Ador Diagnostics Covid-19 Diagnostic Product Offered
Table 64. Ador Diagnostics Main Business
Table 65. Ador Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Ador Diagnostics Latest Developments
Table 67. Akkoni Biosystems Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 68. Akkoni Biosystems Covid-19 Diagnostic Product Offered
Table 69. Akkoni Biosystems Main Business
Table 70. Akkoni Biosystems Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Akkoni Biosystems Latest Developments
Table 72. Alveo Technologies Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 73. Alveo Technologies Covid-19 Diagnostic Product Offered
Table 74. Alveo Technologies Main Business
Table 75. Alveo Technologies Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Alveo Technologies Latest Developments
Table 77. Applied BioCode Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 78. Applied BioCode Covid-19 Diagnostic Product Offered
Table 79. Applied BioCode Main Business
Table 80. Applied BioCode Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Applied BioCode Latest Developments
Table 82. Aus Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 83. Aus Diagnostics Covid-19 Diagnostic Product Offered
Table 84. Aus Diagnostics Main Business
Table 85. Aus Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Aus Diagnostics Latest Developments
Table 87. BD Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 88. BD Diagnostics Covid-19 Diagnostic Product Offered
Table 89. BD Diagnostics Main Business
Table 90. BD Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. BD Diagnostics Latest Developments
Table 92. Biocartis Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 93. Biocartis Covid-19 Diagnostic Product Offered
Table 94. Biocartis Main Business
Table 95. Biocartis Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Biocartis Latest Developments
Table 97. BioFire Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 98. BioFire Diagnostics Covid-19 Diagnostic Product Offered
Table 99. BioFire Diagnostics Main Business
Table 100. BioFire Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. BioFire Diagnostics Latest Developments
Table 102. bioMйrieux Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 103. bioMйrieux Covid-19 Diagnostic Product Offered
Table 104. bioMйrieux Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. bioMйrieux Main Business
Table 106. bioMйrieux Latest Developments
Table 107. Bio-Rad Laboratories Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 108. Bio-Rad Laboratories Covid-19 Diagnostic Product Offered
Table 109. Bio-Rad Laboratories Main Business
Table 110. Bio-Rad Laboratories Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Bio-Rad Laboratories Latest Developments
Table 112. Bosch Healthcare Solutions GmbH Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 113. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product Offered
Table 114. Bosch Healthcare Solutions GmbH Main Business
Table 115. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Bosch Healthcare Solutions GmbH Latest Developments
Table 117. Cepheid Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 118. Cepheid Covid-19 Diagnostic Product Offered
Table 119. Cepheid Main Business
Table 120. Cepheid Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Cepheid Latest Developments
Table 122. Co-Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 123. Co-Diagnostics Covid-19 Diagnostic Product Offered
Table 124. Co-Diagnostics Main Business
Table 125. Co-Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Co-Diagnostics Latest Developments
Table 127. Cue Health Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 128. Cue Health Covid-19 Diagnostic Product Offered
Table 129. Cue Health Main Business
Table 130. Cue Health Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Cue Health Latest Developments
Table 132. Curetis Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 133. Curetis Covid-19 Diagnostic Product Offered
Table 134. Curetis Main Business
Table 135. Curetis Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Curetis Latest Developments
Table 137. Diagenode Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 138. Diagenode Diagnostics Covid-19 Diagnostic Product Offered
Table 139. Diagenode Diagnostics Main Business
Table 140. Diagenode Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Diagenode Diagnostics Latest Developments
Table 142. Diascopic Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 143. Diascopic Covid-19 Diagnostic Product Offered
Table 144. Diascopic Main Business
Table 145. Diascopic Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Diascopic Latest Developments
Table 147. Diasorin Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 148. Diasorin Covid-19 Diagnostic Product Offered
Table 149. Diasorin Main Business
Table 150. Diasorin Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. Diasorin Latest Developments
Table 152. Expedeon Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 153. Expedeon Covid-19 Diagnostic Product Offered
Table 154. Expedeon Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 155. Expedeon Main Business
Table 156. Expedeon Latest Developments
Table 157. Fusion Genomics. Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 158. Fusion Genomics. Covid-19 Diagnostic Product Offered
Table 159. Fusion Genomics. Main Business
Table 160. Fusion Genomics. Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 161. Fusion Genomics. Latest Developments
Table 162. GenePOC Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 163. GenePOC Diagnostics Covid-19 Diagnostic Product Offered
Table 164. GenePOC Diagnostics Main Business
Table 165. GenePOC Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 166. GenePOC Diagnostics Latest Developments
Table 167. GenMark Dx Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 168. GenMark Dx Covid-19 Diagnostic Product Offered
Table 169. GenMark Dx Main Business
Table 170. GenMark Dx Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 171. GenMark Dx Latest Developments
Table 172. Hologic Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 173. Hologic Covid-19 Diagnostic Product Offered
Table 174. Hologic Main Business
Table 175. Hologic Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 176. Hologic Latest Developments
Table 177. Immunexpress Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 178. Immunexpress Covid-19 Diagnostic Product Offered
Table 179. Immunexpress Main Business
Table 180. Immunexpress Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 181. Immunexpress Latest Developments
Table 182. Inflammatix Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 183. Inflammatix Covid-19 Diagnostic Product Offered
Table 184. Inflammatix Main Business
Table 185. Inflammatix Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 186. Inflammatix Latest Developments
Table 187. Invetech Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 188. Invetech Covid-19 Diagnostic Product Offered
Table 189. Invetech Main Business
Table 190. Invetech Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 191. Invetech Latest Developments
Table 192. Janssen Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 193. Janssen Diagnostics Covid-19 Diagnostic Product Offered
Table 194. Janssen Diagnostics Main Business
Table 195. Janssen Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 196. Janssen Diagnostics Latest Developments
.
Table 1. Covid-19 Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immunoassay
Table 3. Major Players of Genomic and WGS Role
Table 4. Major Players of rRT-PCR
Table 5. Covid-19 Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 8. Covid-19 Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 11. Global Covid-19 Diagnostic Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Covid-19 Diagnostic Revenue Market Share by Player (2019-2024)
Table 13. Covid-19 Diagnostic Key Players Head office and Products Offered
Table 14. Covid-19 Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Covid-19 Diagnostic Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Covid-19 Diagnostic Market Size Market Share by Regions (2019-2024)
Table 19. Global Covid-19 Diagnostic Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Covid-19 Diagnostic Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Covid-19 Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Covid-19 Diagnostic Market Size Market Share by Country (2019-2024)
Table 23. Americas Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 25. Americas Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 27. APAC Covid-19 Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Covid-19 Diagnostic Market Size Market Share by Region (2019-2024)
Table 29. APAC Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 31. APAC Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 33. Europe Covid-19 Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Covid-19 Diagnostic Market Size Market Share by Country (2019-2024)
Table 35. Europe Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 37. Europe Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Covid-19 Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Covid-19 Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Covid-19 Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Covid-19 Diagnostic
Table 46. Key Market Challenges & Risks of Covid-19 Diagnostic
Table 47. Key Industry Trends of Covid-19 Diagnostic
Table 48. Global Covid-19 Diagnostic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Covid-19 Diagnostic Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Covid-19 Diagnostic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Covid-19 Diagnostic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Abbott Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 53. Abbott Diagnostics Covid-19 Diagnostic Product Offered
Table 54. Abbott Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Abbott Diagnostics Main Business
Table 56. Abbott Diagnostics Latest Developments
Table 57. Accelerate Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 58. Accelerate Diagnostics Covid-19 Diagnostic Product Offered
Table 59. Accelerate Diagnostics Main Business
Table 60. Accelerate Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Accelerate Diagnostics Latest Developments
Table 62. Ador Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 63. Ador Diagnostics Covid-19 Diagnostic Product Offered
Table 64. Ador Diagnostics Main Business
Table 65. Ador Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Ador Diagnostics Latest Developments
Table 67. Akkoni Biosystems Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 68. Akkoni Biosystems Covid-19 Diagnostic Product Offered
Table 69. Akkoni Biosystems Main Business
Table 70. Akkoni Biosystems Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Akkoni Biosystems Latest Developments
Table 72. Alveo Technologies Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 73. Alveo Technologies Covid-19 Diagnostic Product Offered
Table 74. Alveo Technologies Main Business
Table 75. Alveo Technologies Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Alveo Technologies Latest Developments
Table 77. Applied BioCode Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 78. Applied BioCode Covid-19 Diagnostic Product Offered
Table 79. Applied BioCode Main Business
Table 80. Applied BioCode Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Applied BioCode Latest Developments
Table 82. Aus Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 83. Aus Diagnostics Covid-19 Diagnostic Product Offered
Table 84. Aus Diagnostics Main Business
Table 85. Aus Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Aus Diagnostics Latest Developments
Table 87. BD Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 88. BD Diagnostics Covid-19 Diagnostic Product Offered
Table 89. BD Diagnostics Main Business
Table 90. BD Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. BD Diagnostics Latest Developments
Table 92. Biocartis Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 93. Biocartis Covid-19 Diagnostic Product Offered
Table 94. Biocartis Main Business
Table 95. Biocartis Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Biocartis Latest Developments
Table 97. BioFire Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 98. BioFire Diagnostics Covid-19 Diagnostic Product Offered
Table 99. BioFire Diagnostics Main Business
Table 100. BioFire Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. BioFire Diagnostics Latest Developments
Table 102. bioMйrieux Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 103. bioMйrieux Covid-19 Diagnostic Product Offered
Table 104. bioMйrieux Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. bioMйrieux Main Business
Table 106. bioMйrieux Latest Developments
Table 107. Bio-Rad Laboratories Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 108. Bio-Rad Laboratories Covid-19 Diagnostic Product Offered
Table 109. Bio-Rad Laboratories Main Business
Table 110. Bio-Rad Laboratories Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Bio-Rad Laboratories Latest Developments
Table 112. Bosch Healthcare Solutions GmbH Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 113. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product Offered
Table 114. Bosch Healthcare Solutions GmbH Main Business
Table 115. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Bosch Healthcare Solutions GmbH Latest Developments
Table 117. Cepheid Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 118. Cepheid Covid-19 Diagnostic Product Offered
Table 119. Cepheid Main Business
Table 120. Cepheid Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Cepheid Latest Developments
Table 122. Co-Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 123. Co-Diagnostics Covid-19 Diagnostic Product Offered
Table 124. Co-Diagnostics Main Business
Table 125. Co-Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Co-Diagnostics Latest Developments
Table 127. Cue Health Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 128. Cue Health Covid-19 Diagnostic Product Offered
Table 129. Cue Health Main Business
Table 130. Cue Health Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Cue Health Latest Developments
Table 132. Curetis Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 133. Curetis Covid-19 Diagnostic Product Offered
Table 134. Curetis Main Business
Table 135. Curetis Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Curetis Latest Developments
Table 137. Diagenode Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 138. Diagenode Diagnostics Covid-19 Diagnostic Product Offered
Table 139. Diagenode Diagnostics Main Business
Table 140. Diagenode Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Diagenode Diagnostics Latest Developments
Table 142. Diascopic Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 143. Diascopic Covid-19 Diagnostic Product Offered
Table 144. Diascopic Main Business
Table 145. Diascopic Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Diascopic Latest Developments
Table 147. Diasorin Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 148. Diasorin Covid-19 Diagnostic Product Offered
Table 149. Diasorin Main Business
Table 150. Diasorin Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. Diasorin Latest Developments
Table 152. Expedeon Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 153. Expedeon Covid-19 Diagnostic Product Offered
Table 154. Expedeon Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 155. Expedeon Main Business
Table 156. Expedeon Latest Developments
Table 157. Fusion Genomics. Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 158. Fusion Genomics. Covid-19 Diagnostic Product Offered
Table 159. Fusion Genomics. Main Business
Table 160. Fusion Genomics. Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 161. Fusion Genomics. Latest Developments
Table 162. GenePOC Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 163. GenePOC Diagnostics Covid-19 Diagnostic Product Offered
Table 164. GenePOC Diagnostics Main Business
Table 165. GenePOC Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 166. GenePOC Diagnostics Latest Developments
Table 167. GenMark Dx Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 168. GenMark Dx Covid-19 Diagnostic Product Offered
Table 169. GenMark Dx Main Business
Table 170. GenMark Dx Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 171. GenMark Dx Latest Developments
Table 172. Hologic Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 173. Hologic Covid-19 Diagnostic Product Offered
Table 174. Hologic Main Business
Table 175. Hologic Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 176. Hologic Latest Developments
Table 177. Immunexpress Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 178. Immunexpress Covid-19 Diagnostic Product Offered
Table 179. Immunexpress Main Business
Table 180. Immunexpress Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 181. Immunexpress Latest Developments
Table 182. Inflammatix Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 183. Inflammatix Covid-19 Diagnostic Product Offered
Table 184. Inflammatix Main Business
Table 185. Inflammatix Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 186. Inflammatix Latest Developments
Table 187. Invetech Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 188. Invetech Covid-19 Diagnostic Product Offered
Table 189. Invetech Main Business
Table 190. Invetech Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 191. Invetech Latest Developments
Table 192. Janssen Diagnostics Details, Company Type, Covid-19 Diagnostic Area Served and Its Competitors
Table 193. Janssen Diagnostics Covid-19 Diagnostic Product Offered
Table 194. Janssen Diagnostics Main Business
Table 195. Janssen Diagnostics Covid-19 Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 196. Janssen Diagnostics Latest Developments
LIST OF FIGURES
.
Figure 1. Covid-19 Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Covid-19 Diagnostic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Covid-19 Diagnostic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Covid-19 Diagnostic Sales Market Share by Country/Region (2023)
Figure 8. Covid-19 Diagnostic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Covid-19 Diagnostic Market Size Market Share by Type in 2023
Figure 10. Covid-19 Diagnostic in Hospital
Figure 11. Global Covid-19 Diagnostic Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Covid-19 Diagnostic in Laboratory
Figure 13. Global Covid-19 Diagnostic Market: Laboratory (2019-2024) & ($ Millions)
Figure 14. Global Covid-19 Diagnostic Market Size Market Share by Application in 2023
Figure 15. Global Covid-19 Diagnostic Revenue Market Share by Player in 2023
Figure 16. Global Covid-19 Diagnostic Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Covid-19 Diagnostic Market Size 2019-2024 ($ Millions)
Figure 18. APAC Covid-19 Diagnostic Market Size 2019-2024 ($ Millions)
Figure 19. Europe Covid-19 Diagnostic Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Covid-19 Diagnostic Market Size 2019-2024 ($ Millions)
Figure 21. Americas Covid-19 Diagnostic Value Market Share by Country in 2023
Figure 22. United States Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Covid-19 Diagnostic Market Size Market Share by Region in 2023
Figure 27. APAC Covid-19 Diagnostic Market Size Market Share by Type in 2023
Figure 28. APAC Covid-19 Diagnostic Market Size Market Share by Application in 2023
Figure 29. China Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Covid-19 Diagnostic Market Size Market Share by Country in 2023
Figure 36. Europe Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Figure 37. Europe Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Figure 38. Germany Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 52. APAC Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 53. Europe Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 55. United States Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 56. Canada Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 59. China Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 60. Japan Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 61. Korea Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 63. India Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 64. Australia Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 65. Germany Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 66. France Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 67. UK Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 68. Italy Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 69. Russia Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 70. Spain Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 73. Israel Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 76. Global Covid-19 Diagnostic Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Covid-19 Diagnostic Market Size Market Share Forecast by Application (2025-2030)
.
Figure 1. Covid-19 Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Covid-19 Diagnostic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Covid-19 Diagnostic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Covid-19 Diagnostic Sales Market Share by Country/Region (2023)
Figure 8. Covid-19 Diagnostic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Covid-19 Diagnostic Market Size Market Share by Type in 2023
Figure 10. Covid-19 Diagnostic in Hospital
Figure 11. Global Covid-19 Diagnostic Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Covid-19 Diagnostic in Laboratory
Figure 13. Global Covid-19 Diagnostic Market: Laboratory (2019-2024) & ($ Millions)
Figure 14. Global Covid-19 Diagnostic Market Size Market Share by Application in 2023
Figure 15. Global Covid-19 Diagnostic Revenue Market Share by Player in 2023
Figure 16. Global Covid-19 Diagnostic Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Covid-19 Diagnostic Market Size 2019-2024 ($ Millions)
Figure 18. APAC Covid-19 Diagnostic Market Size 2019-2024 ($ Millions)
Figure 19. Europe Covid-19 Diagnostic Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Covid-19 Diagnostic Market Size 2019-2024 ($ Millions)
Figure 21. Americas Covid-19 Diagnostic Value Market Share by Country in 2023
Figure 22. United States Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Covid-19 Diagnostic Market Size Market Share by Region in 2023
Figure 27. APAC Covid-19 Diagnostic Market Size Market Share by Type in 2023
Figure 28. APAC Covid-19 Diagnostic Market Size Market Share by Application in 2023
Figure 29. China Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Covid-19 Diagnostic Market Size Market Share by Country in 2023
Figure 36. Europe Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Figure 37. Europe Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Figure 38. Germany Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Covid-19 Diagnostic Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Covid-19 Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 52. APAC Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 53. Europe Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 55. United States Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 56. Canada Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 59. China Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 60. Japan Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 61. Korea Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 63. India Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 64. Australia Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 65. Germany Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 66. France Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 67. UK Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 68. Italy Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 69. Russia Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 70. Spain Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 73. Israel Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Covid-19 Diagnostic Market Size 2025-2030 ($ Millions)
Figure 76. Global Covid-19 Diagnostic Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Covid-19 Diagnostic Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Plastic Bandages Market Growth 2025-2031
US$ 3,660.00
December 2024
117 pages
Global Fibrinolytic Therapy Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
81 pages
Global Sustained Release Film Coating Market Growth 2024-2030
US$ 3,660.00
June 2024
76 pages
Global Personalized Orthopaedic Implant Market Growth 2023-2029
US$ 3,660.00
February 2023
102 pages
Global Peripheral Guide Wires Market Growth 2026-2032
US$ 3,660.00
July 2026
153 pages
